Schond Greenway Email
Chief Financial Officer . KaliVir Immunotherapeutics
How to contact Schond Greenway
Join and see Schond's contact info for free!Current Roles
Employees:
45Revenue:
$4.5MAbout
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells. This modality is known as oncolytic viral immunotherapy. KaliVir’s cutting-edge, next generation oncolytic viral immunotherapy programs combine technologies developed in-house and licensed from University of Pittsburgh’s world-class oncolytic virus and immunotherapy research programs.KaliVir Immunotherapeutics Address
240 Alpha DrivePittsburgh, PA
United States